Huperzine A 250 mcg
Goals
$17.82 $0.19 per serving
Product analysis
Huperzine A 250 mcg offers a clearly labeled clubmoss extract at a favorable serving cost. Findings from a disease-treatment setting do not establish memory benefits for healthy adults.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The clubmoss whole-plant extract is named, making the preparation clearer. Its form quality and absorption remain uncertain.
Ingredient Transparency100
The huperzine amount and extract source are listed. That makes the declared preparation straightforward to compare.
Value For Money100
The serving cost compares favorably for the declared huperzine amount. That does not establish a routine memory benefit.
Customer Satisfaction86
Customer ratings are favorable, supported by many ratings. Those opinions do not establish cognitive benefits in healthy adults.
Product Focus63
The formula has a clear single-ingredient focus, but routine memory enhancement remains unestablished. Effects on a brain messenger do not demonstrate improved everyday cognition.
- Format
Capsule - Container
- 90 Capsule(s)
- Per serving
- $0.19
- Also available
Huperzine A 250 mcg- Customer rating
- 4.7 · 2,453 ratings
Goals
Impact
Highest effect
Huperzine · 250 mcg
Huperzine acts on the breakdown of acetylcholine, a chemical messenger involved in brain function. This mechanism does not establish improved attention, memory or routine brain maintenance in healthy adults. The supplied disease-treatment findings do not support general cognitive enhancement, and the clubmoss extract declaration does not justify a cycling schedule.
How this product is rated for Brain Health
Ingredient fit95
Huperzine is the sole ingredient contributing to the saved findings, and its recorded amount reaches the saved endpoint. This does not establish a useful amount for healthy-adult cognition.
Goal fit
Huperzine supplies the product’s recorded connection to this goal; the product is also linked to other goals.
Dose adequacy
The recorded amount reaches the saved endpoint, without establishing an effective amount for routine healthy-adult cognition.
Pathways54
The findings concentrate on acetylcholine signalling. This mechanistic connection does not demonstrate a memory benefit.
Depth
Acetylcholine signalling is the strongest recorded pathway.
Breadth
Only acetylcholine signalling reaches the saved coverage threshold.
Evidence90
Huperzine leads the saved evidence finding and meets its preparation criteria. Disease-treatment evidence does not establish routine healthy-adult benefit.
Evidence strength
Huperzine is the sole source of the saved evidence finding; its mechanism alone does not demonstrate cognitive benefit.
Studied preparation
The clubmoss declaration meets the saved preparation criteria, without establishing equivalence for healthy-adult cognitive benefit.
Formulation logic100
The recorded amount meets the saved criteria and no partner is missing. Caffeine-related conflicts do not apply because caffeine is absent.
Partner coverage
Every contributing ingredient can act without a missing required partner.
Conflicts
Caffeine-related conflicts are inapplicable because caffeine is absent.
Effective doses
Every contributing ingredient meets the saved minimum amount criterion; this is not proof of cognitive benefit.
Impact
Lower effect
Huperzine · 250 mcg
Impact
Lower effect
Huperzine · 250 mcg
Huperzine Not classified
No linked studies yet.
Impact
Highest effect
Huperzine · 250 mcg
Huperzine inhibits the enzyme that breaks down acetylcholine, but this mechanism does not establish routine memory enhancement. The supplied trial concerned mild-to-moderate Alzheimer disease, so its treatment context cannot be transferred to healthy adults. The declared amount does not establish a general cognitive benefit or an equivalent treatment regimen.
How this product is rated for Cognitive Support
Ingredient fit95
Huperzine contributes to the saved ingredient-fit finding. The retained amounts reach their reference comparisons.
Goal fit
The retained ingredients and the product’s other active ingredients and linked uses determine how specifically the formula addresses cognition.
Dose adequacy
The retained amounts reach the saved reference comparisons; those comparisons do not establish effective doses for broad cognitive enhancement.
Pathways60
The strongest recorded connection is acetylcholine signalling. Coverage is concentrated in one tracked pathway.
Depth
The strongest recorded connection is acetylcholine signalling; this mapping does not establish an improvement in cognitive performance.
Breadth
Only one tracked pathway reaches the coverage threshold, leaving the recorded coverage narrow.
Evidence91
Huperzine leads the saved evidence finding. The supplied limitations determine whether this concerns narrow tasks, selected populations or normal nutritional roles.
Evidence strength
Huperzine leads the saved evidence finding; the supplied task, population and preparation limitations still restrict the cognitive benefits that can be described.
Studied preparation
The saved preparation comparison recognizes the retained forms; it does not establish a clinical trial of this complete product.
Formulation logic100
No required partner was missing and no configured conflict was found. The retained ingredients meet the minimum amount criterion.
Partner coverage
No missing required partner was identified for the retained ingredients. This does not establish extra benefit from combining them.
Conflicts
No configured ingredient conflict was identified; this does not establish overall safety or individual suitability.
Effective doses
All retained ingredients meet the minimum amount criterion; this is not a proven effective cognitive dose.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Huperzine A (Toothed Clubmoss Whole Plant Extract) | 250 mcg |
Huperzine (Toothed Clubmoss Whole Plant Extract) · 250 mcg OverallScore67
A serving lists 250 mcg of huperzine A, a relatively high amount. The Huperzia serrata extract is identified, but its concentration is not established in the saved facts.
How this ingredient is rated
Active Ingredient Quality & Bioavailability60
The source is a Huperzia serrata extract; its concentration is not established.
Source and Standardization Clarity
A Huperzia serrata extract is identified, but its standardization percentage is not available in the saved facts.
Dose, Safety & Label Transparency58
The serving lists 250 mcg of huperzine A, a relatively high amount.
Huperzine A Dosage Efficacy
The listed 250 mcg of huperzine A is a relatively high serving amount.
Cycling Guidance and Transparency
The active amount is listed as 250 mcg per serving; no specific cycling instructions are recorded in the saved facts.
Value100
The whole-product price is about $0.08 per 100 mcg of recorded huperzine A.
Price per 100mcg of Huperzine A
Based on the whole-product price and recorded amount, the cost is about $0.08 per 100 mcg of huperzine A.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
- [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
- Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
- Treatment with Huperzine A improves cognition in vascular dementia patients.
- Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
- Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
- [Drug evaluation of huperzine A in the treatment of senile memory disorders].
- Effect of Huperzine A on Cognitive Function and Perception of Effort during Exercise: A Randomized Double-Blind Crossover Trial.